Management of resistant post-transplant lymphoproliferative disorder: CAR-T is a new option
J Styczynski, J Sadlok, T Styczynski… - Anticancer …, 2022 - ar.iiarjournals.org
This is a review of the therapeutic options for resistant/refractory post-transplant lymphoproliferative
disorder (PTLD) in relation to Chimeric antigen receptor-T cell (CAR-T) therapy. Out …
disorder (PTLD) in relation to Chimeric antigen receptor-T cell (CAR-T) therapy. Out …
[HTML][HTML] The effect of roast profiles on the dynamics of titratable acidity during coffee roasting
L Anokye-Bempah, T Styczynski… - Scientific Reports, 2024 - nature.com
Coffee professionals have long known that the “roast profile,” ie, the temperature versus
time inside the roaster, strongly affects the flavor and quality of the coffee. A particularly …
time inside the roaster, strongly affects the flavor and quality of the coffee. A particularly …
[HTML][HTML] … cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell …
…, B Verhoeven, N Kröger, J Styczynski… - Bone marrow …, 2020 - nature.com
The new coronavirus SARS-CoV-2 has rapidly spread over the world causing the disease
by WHO called COVID-19. This pandemic poses unprecedented stress on the health care …
by WHO called COVID-19. This pandemic poses unprecedented stress on the health care …
Letermovir use in children after hematopoietic cell transplantation: summary of reported data
T Styczyński, J Sadlok… - Acta Haematologica …, 2023 - journals.viamedica.pl
… Styczyński J. Prophylaxis vs preemptive therapy in prevention of CMV infection: new insight
… Czyżewski K, Styczyński J. Real-world experience with letermovir in primary prophylaxis of …
… Czyżewski K, Styczyński J. Real-world experience with letermovir in primary prophylaxis of …
Hematology on Twitter
T Styczyński, J Sadlok… - Acta Haematologica …, 2023 - journals.viamedica.pl
Twitter’s impact on information dissemination and the possibility of exchanging opinions
between people around the world have made this social platform particularly appealing for …
between people around the world have made this social platform particularly appealing for …
[HTML][HTML] Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow …
…, C Rioufol, R Saccardi, JA Snowden, J Styczynski… - Annals of …, 2022 - Elsevier
Background Several commercial and academic autologous chimeric antigen receptor T-cell
(CAR-T) products targeting CD19 have been approved in Europe for relapsed/refractory B-…
(CAR-T) products targeting CD19 have been approved in Europe for relapsed/refractory B-…
Vaccinations following CAR-T cell therapy: summary of reported cases and state-of-the-art review of current recommendations
J Styczyński, T Styczyński, J Sadlok… - Acta Haematologica …, 2022 - journals.viamedica.pl
Introduction: Chimeric antigen receptor T-cell (CAR-T) therapy is a modern breakthrough
technology used in the treatment of B-lineage lymphoid malignancies. These malignancies …
technology used in the treatment of B-lineage lymphoid malignancies. These malignancies …
Varicosity of the lower part of the vertebral canal
S Zarski, T Styczyński - Neurologia i Neurochirurgia Polska, 1978 - europepmc.org
In a group of 300 patients with the diagnosis of lumbar nucleus pulposus prolapse treated
surgically the authors found in 4 cases not the expected prolapse but varicose blood vessels …
surgically the authors found in 4 cases not the expected prolapse but varicose blood vessels …
Infection With Saprochaete Clavata in Children After Hematopoietic Cell Transplantation
T Styczynski, J Sadlok… - Journal of Pediatric …, 2023 - journals.lww.com
Septic shock is a very rare manifestation of invasive fungal disease (IFD) in children after
allogeneic hematopoietic cell transplantation (allo-HCT). The objective of this paper is analysis …
allogeneic hematopoietic cell transplantation (allo-HCT). The objective of this paper is analysis …
[HTML][HTML] Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood …
…, JA Snowden, M Srour, J Styczynski… - …, 2020 - ncbi.nlm.nih.gov
Chimeric antigen receptor (CAR) T cells are a novel class of anti-cancer therapy in which
autologous or allogeneic T cells are engineered to express a CAR targeting a membrane …
autologous or allogeneic T cells are engineered to express a CAR targeting a membrane …